Chlamydia is the most commonly diagnosed sexually transmitted infection (STI) in the United Kingdom. One of the reasons it spreads so readily is that the majority of people who have it experience no symptoms at all — making chlamydia screening a genuinely important tool for protecting sexual health at an individual and population level. Understanding what screening means, who it may benefit, and how to access it is an essential first step for anyone considering getting tested.
This article explains what chlamydia screening involves, how it differs from diagnostic testing, who is commonly advised to consider testing, age-related guidance, screening considerations during pregnancy, and what to expect after a test result.
What Is Chlamydia Screening?
Chlamydia screening refers to testing people who have no symptoms of infection in order to detect chlamydia before it causes harm. The aim is to identify infection early so that treatment can be offered promptly and onward transmission can be reduced.
This is distinct from diagnostic testing, which occurs when someone has symptoms — such as unusual discharge, pelvic pain or discomfort when passing urine — or when they have been told by a sexual partner that they may have been exposed to an STI. Both situations may require a chlamydia test, but the clinical context, urgency and follow-up differ.
Screening can be offered through NHS sexual health clinics (also called GUM clinics), GP practices, pharmacies participating in local sexual health schemes, online services, and private providers. The route a person chooses may depend on their circumstances, preferences and access to services.
Who Should Consider Chlamydia Screening?
Because chlamydia so often causes no noticeable symptoms, many people who have it are unaware. This makes routine screening valuable for a broad range of sexually active people, particularly those with recognised risk factors.
Factors that may make chlamydia screening more relevant for an individual include:
These are general indicators and not a definitive list. Individual circumstances vary, and a sexual health professional can advise on whether screening is appropriate based on a person's specific history. Sexual health screening more broadly — including for other STIs — may also be worth discussing depending on circumstances.
Related Test
Full Blood Count
Complete blood analysis • Same-day appointments • UKAS-accredited lab
Chlamydia Screening Age: What the Guidance Says
Age is one of the most widely discussed factors in chlamydia screening. Rates of chlamydia are consistently highest among younger people, which has led to targeted screening initiatives in different parts of the UK.
The National Chlamydia Screening Programme (England)
In England, the National Chlamydia Screening Programme (NCSP) has historically focused on people aged 15 to 24, encouraging opportunistic testing through sexual health clinics, GP practices and community venues. The programme has evolved over time, with guidance updated by NHS England and the UK Health Security Agency (UKHSA). Annual screening or screening at each new partner has been recommended for sexually active people under 25.
It is important to note that the NCSP applies specifically to England and is a public health programme rather than a blanket entitlement for every individual aged 15–24. Eligibility may depend on local commissioning, how a service is accessed, and individual clinical assessment.
Scotland, Wales and Northern Ireland
Scotland, Wales and Northern Ireland each have their own sexual health frameworks and screening approaches. Guidance and programme availability may differ from those in England. For example:
Anyone in these nations seeking guidance should consult their local NHS sexual health service or GP for advice relevant to their area.
Older Adults
Chlamydia is not exclusively an infection of younger people. Sexually active adults of any age can acquire chlamydia. People over 25 who have new or multiple partners, or who have not been tested recently, should not assume that the age focus of the NCSP means they are not at risk. Clinical assessment remains the appropriate route for guidance.
Chlamydia Screening in Women
Chlamydia screening in women deserves particular attention because the potential long-term consequences of untreated infection can be significant. Untreated chlamydia in women can lead to pelvic inflammatory disease (PID), which may in turn affect fertility, cause chronic pelvic pain, or increase the risk of ectopic pregnancy.
Despite these risks, the majority of women with chlamydia have no symptoms and may be unaware they are infected. Some may experience:
However, the absence of these symptoms does not mean chlamydia is not present. This is precisely why screening — testing people who feel well — is valuable. Regular screening is recommended for sexually active women under 25 in England, and for women of any age with risk factors, in line with clinical advice.
Chlamydia Screening in Pregnancy
Chlamydia screening in pregnancy is an area where careful, nuanced guidance is particularly important. An untreated chlamydia infection during pregnancy can have implications for both the pregnant person and the baby, potentially including premature birth, low birth weight, or transmission of infection to the newborn during delivery, which may cause eye infection (neonatal conjunctivitis) or pneumonia.
In England, routine universal chlamydia screening is not currently part of the standard NHS antenatal screening programme for all pregnancies. However, testing may be offered or recommended in specific circumstances, including when:
If you are pregnant and have any concerns about chlamydia or other STIs, speaking with your midwife, GP or a sexual health specialist is the appropriate first step. They can assess your individual situation and advise on whether testing is indicated. Do not delay seeking advice if you have symptoms or are aware of potential exposure.
The guidance on chlamydia in pregnancy is kept under review, and clinical decisions are always made on an individual basis. If guidance has been updated since this article was published, professional sources including NHS guidance and UKHSA publications should be consulted.
How to Get Tested for Chlamydia
Understanding how to get tested for chlamydia helps remove one of the most common barriers: uncertainty about the process itself.
Sample Types
Chlamydia is typically detected using a nucleic acid amplification test (NAAT), which looks for the genetic material of the bacteria *Chlamydia trachomatis*. The sample required depends on the site of potential infection and is collected differently depending on sex, anatomy and sexual activity:
The appropriate sample type for an individual will depend on their anatomy and sexual history. Providers will guide patients on which samples are needed.
Where to Get Tested
Testing is available through:
If you would like to explore private health screening options, the health screening services at Private Blood Tests London provide a discreet, professional environment for your testing needs. For information on appointment booking, visit the online booking page.
Regardless of where testing is done, following the provider's instructions carefully — regarding sample collection, storage and return — is essential for an accurate result.
Screening Guidelines and Recommendations
UK guidance on chlamydia screening draws on evidence from several authoritative bodies:
Key points from current guidance include:
Symptoms and When to Seek Assessment
Chlamydia is often called a "silent" infection because most people — an estimated 70–80% of women and around 50% of men — have no symptoms at all. However, when symptoms do occur, they may include:
In people with a vagina:
In people with a penis:
At other sites (less commonly recognised):
If you have any of these symptoms, you need clinical assessment — not just screening. Please contact your GP, a sexual health clinic or call NHS 111. Do not rely solely on routine screening advice if you are experiencing symptoms or know you have been exposed.
What Happens After a Test?
Understanding what follows a test result helps reduce anxiety and encourages people to act promptly.
Negative Result
A negative result generally means that no chlamydia was detected in the sample provided. However, a negative result does not guarantee the absence of infection in every circumstance. Factors such as the window period (the time between infection and when a test can reliably detect it) or a sample that did not reach adequate quality may affect results. If you were recently exposed or have ongoing symptoms despite a negative result, further clinical advice is important.
Positive Result
A positive result means chlamydia has been detected. This requires prompt clinical follow-up. Chlamydia is treated effectively with antibiotics, but treatment must be prescribed by a qualified clinician following appropriate assessment. Do not self-treat or delay seeking care.
After a positive result, it is also important to:
For broader guidance on managing your health between appointments, exploring a comprehensive health screening package can help you maintain oversight of your wellbeing year-round.
Prevention and Ongoing Sexual Health
Sexual health is part of overall health, and there is no shame in being proactive about testing. Some general steps that support good sexual health include:
None of these recommendations are about judgement. Regular testing is a responsible, routine part of healthcare for many people, just like checking blood pressure or having a cervical screening. For information about the range of tests available privately, you can visit the Private Blood Tests London homepage or review test pricing information.
Frequently Asked Questions
What does chlamydia screening mean?
Chlamydia screening means testing someone who has no symptoms of infection to find out whether they have chlamydia. The goal is early detection and treatment to prevent complications and further transmission. It differs from testing prompted by symptoms or known exposure to an infected partner.
How do you get tested for chlamydia?
A chlamydia test typically involves providing a urine sample or a swab from the genitals, rectum or throat depending on the type of sexual contact. Samples are analysed using a highly sensitive test called a NAAT. Testing is available through NHS sexual health clinics, GP practices, pharmacies, online services and private clinics.
Who should have chlamydia screening?
Sexually active people under 25 in England are encouraged to screen regularly. People of any age with a new partner, multiple partners or other risk factors should also consider screening. Those with symptoms or known exposure need assessment rather than routine screening alone.
At what age is chlamydia screening recommended?
In England, the National Chlamydia Screening Programme focuses on sexually active people aged 15 to 24. However, chlamydia can affect anyone who is sexually active, and people over 25 with relevant risk factors should also consider testing. Guidance varies across the UK nations.
Is chlamydia screening available during pregnancy?
Testing may be considered in pregnancy if there are symptoms, risk factors or clinical reasons to suspect infection. Routine universal chlamydia screening is not currently part of the standard antenatal programme in England. Pregnant individuals with concerns should speak with their midwife, GP or a sexual health service.
Can you have chlamydia without symptoms?
Yes. The majority of people with chlamydia have no symptoms at all. This is why screening — testing people who feel well — is so important. The absence of symptoms does not mean infection is absent.
How does chlamydia screening work for women?
For people with a vagina, chlamydia screening typically involves a self-taken vaginal swab or a clinician-taken swab. A urine sample may also be used in some settings. The chosen sample is tested in a laboratory. The process is quick, straightforward and non-invasive when a self-swab is used.
What happens after a positive chlamydia screening result?
A positive result requires prompt follow-up with a clinician who can prescribe appropriate antibiotic treatment. You should avoid sexual contact until treatment is complete and clinically cleared, notify recent partners so they can also be tested, and consider re-testing after the recommended interval.
Is the chlamydia screening programme the same across the UK?
No. The National Chlamydia Screening Programme in England has a specific structure focused on under-25s. Scotland, Wales and Northern Ireland have their own sexual health frameworks and approaches, which may differ. Anyone outside England should consult their local NHS sexual health service for relevant guidance.
How often should sexually active people under 25 be screened?
In England, annual screening is commonly recommended for sexually active people under 25, as well as testing with each new sexual partner. A sexual health professional can advise on the most appropriate frequency based on individual circumstances.
What is the difference between chlamydia screening and a chlamydia test for symptoms?
Chlamydia screening refers to testing people without symptoms as a preventive health measure. Testing for symptoms or after known exposure is diagnostic in nature — the clinical context is different and may require a broader assessment, including for other STIs. People with symptoms should seek clinical assessment rather than relying solely on routine screening advice.
Does a negative test result mean I definitely don't have chlamydia?
A negative result means chlamydia was not detected in the sample at that point in time. However, very recent exposure may fall within the window period before the infection is reliably detectable, and sample quality can affect results. If you have symptoms, ongoing concerns or recent high-risk exposure, further professional advice is important even after a negative result.
References and Sources
Disclaimer: This article is intended for general educational purposes and does not constitute medical advice. Always consult a qualified healthcare professional or sexual health service for advice tailored to your individual circumstances. Guidance and screening programmes may be updated; verify current recommendations through NHS or UKHSA sources before making clinical decisions.